| scholarly article | Q13442814 |
| P2093 | author name string | James F Whiting | |
| Douglas W Hanto | |||
| Annie H Fecteau | |||
| Maria H Alonso | |||
| John F Valente | |||
| P433 | issue | 1 | |
| P921 | main subject | liver transplantation | Q1368191 |
| immunosuppression | Q1455316 | ||
| P304 | page(s) | 22-30 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Liver Transplantation | Q15730498 |
| P1476 | title | ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation | |
| P478 | volume | 9 |
| Q41960411 | A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure |
| Q36162536 | A new concept of accommodation in ABO-incompatible kidney transplantation |
| Q37367628 | ABO incompatible liver transplantation as a bridge to treat HELLP syndrome |
| Q91725102 | ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis |
| Q42320578 | ABO-Incompatible Living Donor Liver Transplantation in Focus of Antibody Rebound |
| Q46311043 | ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma |
| Q41516975 | ABO-incompatible liver transplantation for severe hepatitis B patients |
| Q51037308 | ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study. |
| Q93140245 | ABO-incompatible liver transplantation: Is it a viable option with modern innovation? |
| Q46468627 | ABO-incompatible liver transplantation: a new therapeutic option for patients with acute liver failure in Chile |
| Q99630955 | ABO-nonidentical liver transplantation from a deceased donor and clinical outcomes following antibody rebound: A case report |
| Q36206934 | Adult Living Donor Liver Transplantation Across ABO-Incompatibility |
| Q36622173 | Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature |
| Q41642230 | Benefits of fresh-frozen plasma as a replacement fluid to neutralize ABO antibodies |
| Q42881362 | Cascade plasmapheresis (CP) as a preconditioning regime in ABO-incompatible live related donor liver transplants (ABOi-LDLT). |
| Q28077320 | Current techniques for AB0-incompatible living donor liver transplantation |
| Q38029570 | Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: outcome, role of TPE and review of the literature |
| Q43642998 | Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome |
| Q38642534 | Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data |
| Q51357021 | Glycemic management in living donor liver transplantation for patients with glycogen storage disease type 1b. |
| Q38352472 | High molecular weight blood group A trisaccharide-polyacrylamide glycoconjugates as synthetic blood group A antigens for anti-A antibody removal devices. |
| Q46198276 | Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT. |
| Q35864132 | Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation |
| Q57000420 | Liver transplantation in fulminant hepatic failure: experience with 40 adult patients over a 17-year period |
| Q39197753 | Over-expression of heme oxygenase-1 does not protect porcine endothelial cells from human xenoantibodies and complement-mediated lysis |
| Q81422881 | Present status of ABO-incompatible living donor liver transplantation in Japan |
| Q31117692 | Promising recent data on ABO incompatible liver transplantation: restrictions may apply |
| Q33808643 | Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis |
| Q38289602 | Resistance to anti-xenogeneic response by combining alpha-Gal silencing with HO-1 upregulation |
| Q46535233 | Soluble type A substance in fresh-frozen plasma as a function of ABO and Secretor genotypes and Lewis phenotype |
| Q40486090 | Splenectomy is not indicated in living donor liver transplantation |
| Q53868277 | Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases. |
| Q39025342 | Successful ABO-incompatible living-related intestinal transplantation: a 2-year follow-up |
| Q45160757 | Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report |
| Q46512790 | Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan |
| Q35925181 | Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM. |
| Q40706922 | The effects of intraoperative cryoprecipitate transfusion on acute renal failure following orthotropic liver transplantation |
| Q51624479 | Theoretical and experimental analysis of anti-A antibody capture in novel integrated bead and hollow fiber modules. |
| Q37476848 | Therapy related CMML: a case report and review of the literature |
| Q46924230 | Use of ABO-incompatible grafts in living donor liver transplantation--first report from India |
Search more.